Patents Assigned to Tevogen Bio Inc. - Justia Patents Search

Patents Assigned to Tevogen Bio Inc.

COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19

Patent number: 11219684

Abstract: The invention relates to pharmaceutical compositions that contain COVID-19 peptide specific cytotoxic T cells, and to methods for treating or preventing COVID-19 infection.

Type: Grant

Filed: May 7, 2021

Date of Patent: January 11, 2022

Assignee: Tevogen Bio Inc.

Inventor: Ryan Saadi
COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19

Patent number: 11207401

Abstract: The invention relates to pharmaceutical compositions that contain COVID-19 peptide specific cytotoxic T cells, and to methods for treating or preventing COVID-19 infection.

Type: Grant

Filed: May 7, 2021

Date of Patent: December 28, 2021

Assignee: Tevogen Bio Inc.

Inventor: Ryan Saadi
COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19

Patent number: 11191827

Abstract: The invention relates to pharmaceutical compositions that contain COVID-19 peptide specific cytotoxic T cells, and to methods for treating or preventing COVID-19 infection.

Type: Grant

Filed: December 9, 2020

Date of Patent: December 7, 2021

Assignee: Tevogen Bio Inc.

Inventor: Ryan Saadi